LGC BIOSEARCH Webinars

 

IVDR in light of the COVID pandemic: the near future of in vitro diagnostic testing

Abstract

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus. In particular, the in vitro diagnostic (IVD) market experienced a dynamic never seen before: SARS-CoV-2 tests were developed at a record-breaking pace amid global supply shortages as labs struggled to keep up with unprecedented demand.

Topics covered

• Key changes and timeline around IVDR in Europe
• IVDR supply chain implications
• Impact of GDPR, Brexit, Swixit, Turkxit on IVD in Europe

Speakers

Erik Vollebregt
Founding partner, Axon Lawyers